Nebulette Expression Is Associated with Lymph Node Metastasis in Patients with Colorectal Cancer

• Main Authors: Sayed Mostafa Hosseini, Frouzandeh Mahjoubi, Tayebeh Majidzadeh, Fattaneh Khaje-Hosseini, Mahya Haghipanah
• Format: Article
• Language: English
• Published: Iranian Association of Gastroenterology and Hepatology, Shiraz University of Medical Sciences 2018-07-01
• Series: Middle East Journal of Digestive Diseases
• Subjects: Nebullete; LASP2; Colorectal cancer; Lymph node metastasis
• Online Access: http://www.mejdd.org/index.php/mejdd/article/view/1949

BACKGROUND Colorectal cancer (CRC) is one of the most common cancers among men and women worldwide. Cancer metastasis is the main cause of death in patients with cancer. NEBL (nebulette, Gene ID: 10529) protein interacts with thin filaments in the cell and may functionally destabilize focal adhesion composition. There are some studies on NEBL gene expression alteration in cancer. In the presented study we aimed to analyze NEBL gene expression in patients with colorectal cancer to explore possible association of this gene with clinicopathological features in CRC. METHODS Sixty-seven fresh samples of colorectal tumors and adjacent normal tissues were collected from Iranian patients with CRC. Real time polymerase chain reaction was performed to measure the level of NEBL gene expression and its association with clinico-pathological features. RESULTS A significant overexpression with 3 fold increse was seen in NEBL mRNA level in tumoral tissues compared with the adjacent normal tissues. In addition there was a significant association between NEBL gene expression with lymph node metastasis in patients with CRC. CONCLUSION The overexpression of NEBL has the capacity to be considred as a prognostic biomarker in patients with CRC.